News thumbnail
Health / Thu, 20 Aug 2026 BusinessLine

CEPI funds studies on Ebola vaccine protection against Bundibugyo virus - BusinessLine

CEPI funds studies on Ebola vaccine protection against Bundibugyo virus BusinessLineCEPI commits $4.17m to study vaccine protection against Ebola virus Premium Times NigeriaCEPI announces $4.17m for studies assessing existing Ebola vaccines against Bundibugyo strain Manufacturing ChemistNew studies to test whether existing Ebola vaccines can generate immune responses to Bundibugyo ebolavirus CEPICEPI Funds $4.17m Studies To Test Ebola Vaccines Against Bundibugyo Virus News Agency of Nigeria

CEPI funds studies on Ebola vaccine protection against Bundibugyo virus BusinessLineCEPI commits $4.17m to study vaccine protection against Ebola virus Premium Times NigeriaCEPI announces $4.17m for studies assessing existing Ebola vaccines against Bundibugyo strain Manufacturing ChemistNew studies to test whether existing Ebola vaccines can generate immune responses to Bundibugyo ebolavirus CEPICEPI Funds $4.17m Studies To Test Ebola Vaccines Against Bundibugyo Virus News Agency of Nigeria

© All Rights Reserved.